Position in WAT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,350,750
+$589,561 QoQ
Shares Held
6,268
+6.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#363
of 1,173 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in WAT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bryn Mawr Trust Advisors, LLC holds $33,326,657 across 8 Diagnostics & Research names. WAT ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
91,007 | $17,335,013 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
10,158 | $5,347,577 | |
| 3 | A |
Agilent Technologies, Inc.
|
32,301 | $4,290,541 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
4,936 | $2,474,712 | |
| 5 | WAT |
Waters Corp /De/
This page
|
6,268 | $2,350,750 | |
| 6 | LH |
Labcorp Holdings Inc.
|
2,264 | $633,920 | |
| 7 | DGX |
Quest Diagnostics Inc
|
2,283 | $483,881 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,809 | $410,263 |
All Filings in WAT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,350,750 | 6,268 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,761,189 | 5,914 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||